Brief: China Biotech Services Says Unit Entered Site Admission & Investment Deal
28/02/2022 15:17
Feb 28 (Reuters) - China Biotech Services:
* UNIT ENTERED SITE ADMISSION & INVESTMENT DEAL WITH HAINAN
BOAO
LECHENG INTERNATIONAL MEDICAL TOURISM PILOT ZONE ADMINISTRATION
* AGREEMENT IN RELATION TO INVESTMENT IN & CONSTRUCTION OF A
BNCT
CANCER TREATMENT CENTRE IN BOAO LECHENG PILOT ZONE
Source text for Eikon: ID:nHKS67zLN7
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)